StonvexLoading…
StonvexStonvexStonvexCore line items from PII's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-27 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $1.96B | $1.66B | $7.15B | $5.23B | $3.39B |
Operating Income | Not available | $-39.10M | $-348.70M | $-28.60M | $-49.00M |
Net Income | Not available | $-47.40M | $-465.50M | $-161.90M | $-146.10M |
EPS (Diluted) | $0.72 | $-0.83 | $-8.18 | $-2.84 | $-2.57 |
Total Assets | Not available | $5.24B | $4.89B | $5.31B | $5.39B |
Total Liabilities | Not available | $4.48B | $4.05B | $4.14B | $4.19B |
Cash & Equivalents | Not available | $282.00M | $138.00M | $335.50M | $324.30M |
Free Cash Flow OCF − CapEx | Not available | $-349.90M | $558.10M | $444.10M | $327.40M |
Shares Outstanding | Not available | 56.90M | 56.50M | 56.20M | 56.20M |